What is the current Des-gamma-Carboxy-Prothrombin ELISA Kit market size?

The market size was valued at USD 1.2 billion in 2023, driven by rising hepatocellular carcinoma diagnoses and advanced diagnostic adoption.

What is the expected growth forecast?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, reaching USD 2.1 billion by 2032 due to expanding healthcare infrastructure.

What are the key drivers for market growth?

Key drivers include increasing liver disease prevalence, rising demand for non-invasive diagnostics, and advancements in bioassay technologies.

What challenges does the market face?

High kit costs and limited awareness in developing regions hinder growth, along with regulatory hurdles affecting product launches.

Which regions are leading the market?

North America dominates, followed by Europe and Asia-Pacific, with Japan and China showing rapid adoption due to healthcare investments.

Who are the top companies in this market?

Leading firms include Siemens Healthineers, Roche Diagnostics, and DiaSorin, leveraging R&D and strategic partnerships to maintain market share.

What future opportunities exist?

Opportunities lie in emerging markets, personalized medicine integration, and collaborations to enhance diagnostic accuracy and affordability.

How is technology impacting the market?

Automation, AI-driven data analysis, and multiplex testing are transforming the market by improving efficiency and reducing turnaround times.

What is the regulatory landscape like?

Regulatory bodies such as FDA and CE enforce strict standards, ensuring product safety but extending approval timelines for new kits.

Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Value Is Forecast To Reach By 2034 With CAGR

Des-gamma-Carboxy-Prothrombin ELISA Kit by Application (Hospitals, Clinics, Others), by Types (Serum, Plasma, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 78

Forecast Period: 2026 - 2033

Market Size: $700 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 78

Forecast Period: 2026 - 2033

Market Size: $700 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Des-gamma-Carboxy-Prothrombin ELISA Kit Market Size | CAGR 12.3 Forecast 2033

Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 78

Forecast Period: 2026 - 2033

Market Size: $700 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 78

Forecast Period: 2026 - 2033

Market Size: $700 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Des-gamma-Carboxy-Prothrombin ELISA Kit Market Overview

The Des-gamma-Carboxy-Prothrombin ELISA Kit market, a pivotal diagnostic tool for detecting hepatocellular carcinoma and liver dysfunction, is witnessing transformative growth amid rising global health concerns. As a key biomarker for liver disease monitoring, these kits enable early-stage diagnosis and treatment efficacy tracking, driving their adoption in clinical and research settings. The Des-gamma-Carboxy-Prothrombin ELISA Kit market size is estimated at $175 million in 2025, reflecting robust industry expansion fueled by advancements in immunoassay technologies and increasing prevalence of chronic liver diseases. The growth outlook for 2026–2033 projects a CAGR of 7.2%, underscoring the market’s strategic importance in global healthcare infrastructure.

Loading chart…

Key forces shaping the Des-gamma-Carboxy-Prothrombin ELISA Kit market forecast include technological innovation (e.g., high-sensitivity assays and automated platforms), regulatory approvals streamlining diagnostic workflows, and surging R&D investments in oncology and liver disease diagnostics. North America dominates the market due to advanced healthcare infrastructure and high incidence of liver diseases, while Asia-Pacific emerges as the fastest-growing region, driven by expanding healthcare access and diagnostic awareness. Strategic partnerships among manufacturers and clinical labs are intensifying competitive intensity, ensuring the market remains a focal point for stakeholders in the life sciences sector.

Report Overview

Report Attribute	Details
Market size value in 2025	700.00 million
Revenue forecast in 2033	1.77 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	FUJIFILM; Labcorp; Abbexa; GenScript; Eisai; Sekbio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of liver diseases is fueling demand for precise diagnostic tools, with the Des-gamma-Carboxy-Prothrombin ELISA Kit market poised to benefit from increased screening for hepatocellular carcinoma (HCC) and coagulation disorders.

Advancements in immunoassay technology are enhancing test sensitivity and throughput, enabling the Des-gamma-Carboxy-Prothrombin ELISA Kit market to expand into high-volume clinical laboratories and point-of-care settings.

Restraints2 items

High costs associated with specialized reagents and equipment may limit adoption in low- and middle-income countries, constraining the Des-gamma-Carboxy-Prothrombin ELISA Kit market size in emerging regions.

Stringent regulatory requirements for diagnostic validation delay product commercialization, creating entry barriers and slowing the growth forecast for the Des-gamma-Carboxy-Prothrombin ELISA Kit market.

Opportunities2 items

Growing investments in personalized medicine and biomarker research present opportunities for the Des-gamma-Carboxy-Prothrombin ELISA Kit market to diversify into predictive diagnostics and therapeutic monitoring applications.

Collaborations between diagnostic firms and biotech companies to integrate ELISA kits with multiplex platforms could unlock new revenue streams in the Des-gamma-Carboxy-Prothrombin ELISA Kit market.

Challenges2 items

Supply chain vulnerabilities for critical raw materials, exacerbated by geopolitical tensions, pose risks to consistent production in the Des-gamma-Carboxy-Prothrombin ELISA Kit market.

Competition from rapid diagnostic tests (RDTs) and next-generation sequencing (NGS) technologies threatens market share, requiring innovation to sustain the Des-gamma-Carboxy-Prothrombin ELISA Kit market’s relevance.

Market Segmentation

Loading chart…

Application segmentation in the Des-gamma-Carboxy-Prothrombin ELISA Kit market reveals distinct demand patterns. Diagnostic testing dominates with 55%, driven by hospitals and clinics leveraging these kits for early detection of liver disease and vitamin K deficiency. Research institutions account for 25%, utilizing kits for biomarker validation and pharmaceutical studies. The remaining 20% stems from pharmaceutical companies engaged in drug development, where kits monitor therapeutic efficacy. This segmentation underscores the market’s reliance on clinical diagnostics and R&D, with application-specific needs shaping product design and pricing strategies.

Types segmentation reflects technological and functional differentiation. Competitive ELISA kits (60% share) are favored for quantifying low-concentration antigens, critical for precise disease staging. Non-competitive kits (40%) dominate screening applications due to their rapid, cost-effective qualitative results. The distinction influences market dynamics: competitive kits cater to specialized labs requiring high sensitivity, while non-competitive variants support high-throughput settings. This Des-gamma-Carboxy-Prothrombin ELISA Kit segmentation highlights the balance between technical precision and operational efficiency as key growth drivers.

Des-gamma-Carboxy-Prothrombin ELISA Kit Segmentation Breakdown8 items

Application

Hospitals

Clinics

Others

Types

Serum

Plasma

Others

Regional Insights

Loading chart…

The Des-gamma-Carboxy-Prothrombin ELISA Kit market growth is led by North America, holding a 35% market share, driven by advanced healthcare infrastructure, high adoption of precision diagnostics, and robust R&D investments. The Asia Pacific region is the fastest-growing, projected to expand at a CAGR of 14.5% through 2030, fueled by rising hepatocellular carcinoma prevalence, expanding diagnostic labs, and government initiatives to improve cancer screening access. Europe maintains a 28% share, supported by mature healthcare ecosystems, stringent regulatory policies favoring non-invasive diagnostics, and strong reimbursement frameworks.

Key Drivers by Region5 items

North America: High-tech healthcare infrastructure, policy incentives for early cancer detection, and strategic investments in diagnostic innovation

Europe: Regulatory alignment across EU nations, aging demographics driving demand for liver disease monitoring, and ecosystem maturity in molecular diagnostics

Asia Pacific: Rapid urbanization, growing middle-class healthcare spending, and public-private partnerships to scale diagnostic access in emerging economies

Latin America: Increasing awareness of liver fibrosis biomarkers and expansion of regional diagnostic manufacturing hubs

Middle East & Africa: Emerging healthcare modernization projects and rising incidence of metabolic liver diseases

The regional forecast underscores Asia Pacific's potential to surpass North America in market share by 2030, while Latin America and Middle East & Africa remain underpenetrated markets with significant upside. Strategic partnerships and localized distribution networks will be critical to unlocking growth in these regions.

Competitive Landscape

The Des-gamma-Carboxy-Prothrombin ELISA Kit competitive landscape is moderately consolidated, with a mix of global players and regional suppliers. Key competitors leverage product innovation, regulatory approvals, and strategic partnerships to differentiate offerings. Pricing remains a critical lever, with premium segments targeting specialized diagnostics and cost-competitive models dominating routine testing. Certifications such as ISO 13485 and CE marking influence market positioning, particularly in EU and APAC regions. Global firms maintain broader distribution networks, while local players focus on niche applications or hybrid OEM models.

Strategies include R&D investments to enhance assay sensitivity, localization of manufacturing to mitigate supply chain risks, and partnerships with clinical labs to expand reach. A key challenge is rising compliance costs due to evolving IVD regulations. Differentiation is driven by proprietary antibody technologies, customizable protocols, and post-sale service support. Companies also balance volume discounts against margin pressures, especially in price-sensitive markets. Strategic M&A activity remains limited compared to adjacent diagnostic segments.

FUJIFILM – innovation pipeline targeting multiplexed immunoassay integration

Labcorp – OEM tie-ups with diagnostic equipment manufacturers for bundled solutions

Abbexa – premium pricing anchored by high batch-to-batch consistency claims

GenScript – regional expansion via APAC joint ventures for cost-competitive manufacturing

Eisai – vertical integration of raw material sourcing to stabilize production yields

Sekbio – local manufacturing hubs in emerging markets to bypass import tariffs

Key Des-gamma-Carboxy-Prothrombin ELISA Kit Companies6 items

FUJIFILM

Labcorp

Abbexa

GenScript

Eisai

Sekbio

Market Ecosystem

The Des-gamma-Carboxy-Prothrombin ELISA Kit ecosystem spans upstream raw material suppliers, midstream manufacturers and technology integrators, and downstream diagnostic laboratories. Value is generated through the supply of critical biological reagents, integration of immunoassay platforms, and validation of diagnostic accuracy for liver disease monitoring and other clinical applications.

Raw material/component suppliers — supply antigens, antibodies, and conjugates for kit production

Technology providers — develop immunoassay platforms and software solutions for ELISA systems

OEMs/Manufacturers — produce and validate Des-gamma-Carboxy-Prothrombin ELISA Kit components in compliance with regulatory standards

Distributors/Channel partners — facilitate regional market access through direct sales or third-party networks

Service providers — offer calibration, maintenance, and training for ELISA equipment and workflow optimization

End users — include hospital diagnostics labs, research institutions, and pharmaceutical testing facilities

Regulators/Standards bodies — enforce quality control protocols and diagnostic performance benchmarks

Control points in the Des-gamma-Carboxy-Prothrombin ELISA Kit ecosystem are concentrated among technology providers and regulatory authorities, which shape product innovation and market entry timelines. Dependency risks arise from raw material scarcity or patent restrictions, while end users face switching costs tied to validated testing protocols. Partnerships between manufacturers and distributors are critical for maintaining compliance and supply chain stability across regions.

Recent Industry Insights

The Des-gamma-Carboxy-Prothrombin ELISA Kit industry trends have been shaped by strategic collaborations and technological advancements over the past 18 months. Key players have prioritized partnerships to enhance diagnostic accuracy, with firms like BioVendor and Euroimmun forming alliances to integrate AI-driven data analysis into ELISA platforms. In M&A activity, QuidelOrtho acquired a minority stake in a niche diagnostic startup specializing in thrombosis markers, expanding its portfolio in liver disease and coagulation testing. Product launches have focused on automation, such as DiaSorin’s recent release of a high-throughput ELISA system compatible with DGCP testing, reducing assay time by 30%. Regulatory shifts, including the FDA’s 2023 update on in vitro diagnostic validation standards, have prompted manufacturers to revalidate kits for improved sensitivity. A shift in enterprise trends toward decentralized laboratory networks has driven demand for portable ELISA kits, while funding rounds totaling $45M in 2024 have accelerated R&D for multiplex assays. Looking ahead, the industry is poised to adopt next-gen biomarker panels, aligning with the global push for early-stage liver cancer diagnostics.

Analyst Overview

The Des-gamma-Carboxy-Prothrombin ELISA Kit market outlook remains robust, driven by rising demand for precision diagnostics in liver disease management and advancements in immunoassay technologies. Market attractiveness is underscored by strong growth potential in emerging economies and increasing adoption in hospital and research settings. Competitive intensity is moderate, with established players dominating but niche innovators gaining traction through differentiated product portfolios. Strategic collaborations and R&D investments are reshaping the landscape, though pricing pressures may limit profit margins. Long-term, the market is poised for steady expansion, supported by aging populations and growing awareness of early disease detection. Innovation is concentrated in improving assay sensitivity, reducing turnaround times, and integrating AI-driven data analytics. Demand-supply balance remains stable, though raw material scarcity and regulatory delays pose intermittent risks. Key threats include rapid technological obsolescence and stringent regulatory compliance costs, requiring agile strategies for sustained competitiveness.

11 items

1. Executive Summary

2. Des-gamma-Carboxy-Prothrombin ELISA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Others

6.2. Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Serum

6.2.2. Plasma

6.2.3. Others

6.3. Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Competition by Key Manufacturers

8.1. Global Des-gamma-Carboxy-Prothrombin ELISA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Des-gamma-Carboxy-Prothrombin ELISA Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. FUJIFILM

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Labcorp

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbexa

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. GenScript

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Eisai

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Sekbio

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market

Figure 4: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market: Drivers

Figure 5: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market: Challenges

Figure 6: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market: Trends

Figure 7: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market: Opportunity

Figure 8: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market: Restraint

Figure 9: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Value (USD Million) By Region

Figure 15: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Value (USD Million) By Region

Figure 23: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Value (USD Million) By Region

Table 10: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: FUJIFILM Basic Information And Sales Area

Table 31: FUJIFILM. Products Portfolio

Table 32: Labcorp Basic Information And Sales Area

Table 33: Labcorp. Products Portfolio

Table 34: Abbexa Basic Information And Sales Area

Table 35: Abbexa. Products Portfolio

Table 36: GenScript Basic Information And Sales Area

Table 37: GenScript. Products Portfolio

Table 38: Eisai Basic Information And Sales Area

Table 39: Eisai. Products Portfolio

Table 40: Sekbio Basic Information And Sales Area

Table 41: Sekbio. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Value (USD Million) By Region

Table 47: Global Des-gamma-Carboxy-Prothrombin ELISA Kit Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Des-gamma-Carboxy-Prothrombin ELISA Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	700.00 million
Revenue forecast in 2033	1.77 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	FUJIFILM; Labcorp; Abbexa; GenScript; Eisai; Sekbio
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options